Medical Examination and Clinical Diagnosis

The diagnostic value and clinical research of 5′⁃tRF⁃GlyGCC in the early stage of colorectal cancer

  • Long WANG ,
  • Yingmin WU ,
  • Sha SHANG ,
  • Lu WANG
Expand
  • *.Department of Physiology,School of Basic Medical Science,Guizhou Medical University,Guiyang 561113,Guizhou,China

Received date: 2025-02-27

  Online published: 2025-06-19

Abstract

Objective To detect the content of 5'-tRF-GlyGCC in peripheral blood and explore its application value in the early diagnosis of colorectal cancer (CRC). Methods Peripheral blood samples were randomly collected from 99 CRC patients, 11 patients with enteritis, 17 patients with colorectal polyps and 99 healthy individuals in the same period at the Affiliated Hospital of Guizhou Medical University. The content of 5'-tRF-GlyGCC in total RNA of peripheral blood was detected by fluorescence RT-PCR. The receiver operating characteristic curve (ROC) was established to analyze the value of 5'-tRF-GlyGCCcontent in the early diagnosis of CRC and to explore the relationship between its content and the clinical and pathological characteristics of CRC patients. Results The content of 5'-tRF-GlyGCC in the peripheral blood of CRC patients and colorectal polyp patients was significantly higher than that of healthy individuals and patients with enteritis, and the differences were statistically significant (P < 0.05). The area under the curve (AUC) of 5'-tRF-GlyGCC for diagnosing CRC was 0.817 (95%CI: 0.763 ~ 0.871), with a diagnostic sensitivity of 56.7% and a specificity of 99.9%. The content of 5'-tRF-GlyGCC in peripheral blood was significantly positively correlated with the levels of CEA and CA19-9 in CRC patients. Conclusion The detection of 5'-tRF-GlyGCC in peripheral blood has a high application value in the early diagnosis of CRC and can be used for clinical reference and research.

Cite this article

Long WANG , Yingmin WU , Sha SHANG , Lu WANG . The diagnostic value and clinical research of 5′⁃tRF⁃GlyGCC in the early stage of colorectal cancer[J]. The Journal of Practical Medicine, 2025 , 41(11) : 1730 -1735 . DOI: 10.3969/j.issn.1006-5725.2025.11.018

References

1 DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer [J]. Lancet, 2019, 394(10207): 1467-1480. doi:10.1016/s0140-6736(19)32319-0
2 BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi:10.3322/caac.21492
3 郑荣寿, 陈茹, 韩冰峰,等. 2022年中国恶性肿瘤流行情况分析 [J]. 中华肿瘤杂志, 2024, 46(3): 221-231. doi:10.3760/cma.j.cn112152-20240119-00035
4 SETH S, THOMAS C S, FRANK A S. Serrated Colon Polyps as Precursors to Colorectal Cancer [J]. Clin Gastroenterol Hepatol, 2013, 11(7):760-767. doi:10.1016/j.cgh.2012.12.004
5 李华文, 宋育林. 结肠息肉癌变的危险因素分析和风险预测模型构建 [J]. 医学信息, 2024, 37(14): 19-24.
6 WOLF A M D, FONTHAM E T H, CHURCH T R, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society [J]. CA Cancer J Clin, 2018, 68(4):250-281. doi:10.3322/caac.21457
7 AKRAM A, JUANG D, BUSTAMANTE R, et al. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting [J]. Clin Gastroenterol Hepatol, 2017, 15(8):1265-1270. doi:10.1016/j.cgh.2017.01.025
8 LEE Y S, SHIBATA Y, MALHOTRA A, et al. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs) [J]. Genes Dev, 2009, 23(22):2639-2649. doi:10.1101/gad.1837609
9 LIU Q, GREGORY R I. RNAmod: an integrated system for the annotation of mRNA modifications [J]. Nucleic Acids Res, 2019, 47(W1): W548-W55. doi:10.1093/nar/gkz479
10 BALATTI V, NIGITA G, VENEZIANO D, et al. tsRNA signatures in cancer [J]. Proc Natl Acad Sci U S A, 2017, 114(30): 8071-8076. doi:10.1073/pnas.1706908114
11 RAPADO-GONZáLEZ ó, MAJEM B, áLVAREZ-CASTRO A, et al. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis[J]. J Clin Med, 2019, 8(12):2029. doi:10.3390/jcm8122029
12 CHEN W, PENG W, WANG R, et al. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells [J]. Cell Death Dis, 2024, 15(1):102. doi:10.1038/s41419-024-06482-3
13 ZHOU J, WAN F, WANG Y, et al. Small RNA sequencing reveals a novel tsRNA-26576 mediating tumorigenesis of breast cancer [J]. Cancer Manag Res, 2019, 11:3945-3956. doi:10.2147/cmar.s199281
14 KRALJ S, JUKI? M, BREN U. Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein–Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design [J]. Int J Mol Sci, 2021, 23(1):393. doi:10.3390/ijms23010393
15 CHEN Z, QI M, SHEN B, et al. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs [J]. Nucleic Acids Res, 2019, 47(5):2533-2545. doi:10.1093/nar/gky1250
16 WU Y, YANG X, JIANG G, et al. 5′-tRF-GlyGCC: A tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis [J]. Genome Med,2021, 13(1):20. doi:10.1186/s13073-021-00833-x
17 WANG Z, DAN W, ZHANG N, et al. Colorectal cancer and gut microbiota studies in China [J]. Gut Microbes, 2023, 15(1):2236364. doi:10.1080/19490976.2023.2236364
18 辜柏源, 丁永年. 结直肠息肉相关危险因素研究现状 [J]. 齐齐哈尔医学院学报, 2024, 45(14): 1382-6.
19 WANG H, PENG R, WANG J, et al. Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage [J]. Clin Epigenetics, 2018, 10:59. doi:10.1186/s13148-018-0492-1
20 CHANG Y, JIN H, CUI Y, et al. PUS7-dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression [J]. Clin Transl Med, 2024, 14(8):e1811. doi:10.1002/ctm2.1811
Outlines

/